These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30530238)

  • 21. Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review.
    Lees R; Hines LA; D'Souza DC; Stothart G; Di Forti M; Hoch E; Freeman TP
    Psychol Med; 2021 Feb; 51(3):353-364. PubMed ID: 33536109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review.
    Kondo KK; Morasco BJ; Nugent SM; Ayers CK; O'Neil ME; Freeman M; Kansagara D
    Ann Intern Med; 2020 Mar; 172(6):398-412. PubMed ID: 32120384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial.
    Trigo JM; Soliman A; Quilty LC; Fischer B; Rehm J; Selby P; Barnes AJ; Huestis MA; George TP; Streiner DL; Staios G; Le Foll B
    PLoS One; 2018; 13(1):e0190768. PubMed ID: 29385147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cannabis-induced disorders].
    Soyka M; Preuss U; Hoch E
    Nervenarzt; 2017 Mar; 88(3):311-325. PubMed ID: 28236096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
    Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
    JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders.
    Peters EN; Nich C; Carroll KM
    Drug Alcohol Depend; 2011 Nov; 118(2-3):408-16. PubMed ID: 21620591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and consequences of cannabis dependence.
    Budney AJ; Moore BA
    J Clin Pharmacol; 2002 Nov; 42(S1):28S-33S. PubMed ID: 12412833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of cannabis use disorders in people with schizophrenia spectrum disorders - a systematic review.
    Hjorthøj C; Fohlmann A; Nordentoft M
    Addict Behav; 2009; 34(6-7):520-5. PubMed ID: 19268481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.
    Bhardwaj AK; Allsop DJ; Copeland J; McGregor IS; Dunlop A; Shanahan M; Bruno R; Phung N; Montebello M; Sadler C; Gugusheff J; Jackson M; Luksza J; Lintzeris N;
    BMC Psychiatry; 2018 May; 18(1):140. PubMed ID: 29776349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical profile of participants in a brief intervention program for cannabis use disorder.
    Copeland J; Swift W; Rees V
    J Subst Abuse Treat; 2001 Jan; 20(1):45-52. PubMed ID: 11239727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The marijuana withdrawal syndrome: diagnosis and treatment.
    Haney M
    Curr Psychiatry Rep; 2005 Oct; 7(5):360-6. PubMed ID: 16216154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial.
    D'Souza DC; Cortes-Briones J; Creatura G; Bluez G; Thurnauer H; Deaso E; Bielen K; Surti T; Radhakrishnan R; Gupta A; Gupta S; Cahill J; Sherif MA; Makriyannis A; Morgan PT; Ranganathan M; Skosnik PD
    Lancet Psychiatry; 2019 Jan; 6(1):35-45. PubMed ID: 30528676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorder.
    Brezing CA; Choi CJ; Pavlicova M; Brooks D; Mahony AL; Mariani JJ; Levin FR
    Am J Addict; 2018 Mar; 27(2):101-107. PubMed ID: 29457671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Adolescent Cannabis Use Disorders.
    Adams ZW; Marriott BR; Hulvershorn LA; Hinckley J
    Child Adolesc Psychiatr Clin N Am; 2023 Jan; 32(1):141-155. PubMed ID: 36410901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls.
    Rabin RA; Kozak K; Zakzanis KK; Remington G; Stefan C; Budney AJ; George TP
    Schizophr Res; 2018 Apr; 194():47-54. PubMed ID: 28506704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints.
    Borodovsky JT; Sofis MJ; Sherman BJ; Gray KM; Budney AJ
    Psychol Addict Behav; 2022 Aug; 36(5):515-525. PubMed ID: 35084903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychosocial and pharmacological interventions for the treatment of cannabis use disorder.
    Sabioni P; Le Foll B
    F1000Res; 2018; 7():173. PubMed ID: 29497498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of cannabis withdrawal and its influence on adolescents' treatment response and outcomes: a 12-month prospective investigation.
    Greene MC; Kelly JF
    J Addict Med; 2014; 8(5):359-67. PubMed ID: 25100311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Web-Based Self-Help Intervention With and Without Chat Counseling to Reduce Cannabis Use in Problematic Cannabis Users: Three-Arm Randomized Controlled Trial.
    Schaub MP; Wenger A; Berg O; Beck T; Stark L; Buehler E; Haug S
    J Med Internet Res; 2015 Oct; 17(10):e232. PubMed ID: 26462848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence.
    Viola TW; Tractenberg SG; Wearick-Silva LE; Rosa CS; Pezzi JC; Grassi-Oliveira R
    Drug Alcohol Depend; 2014 Nov; 144():153-9. PubMed ID: 25262527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.